Biomarkers in Autosomal Dominant Cerebellar Ataxia

Key facts

Sponsor

Assistance Publique - Hôpitaux de Paris

Principal Investigator

Alexandra DURR, PhD

Assistance Publique - Hôpitaux de Paris

Intervention

metabolic and imaging biomarkers in SCA1,2,3 and 7 patients(other)

Enrollment

102 enrolled

Eligibility

18 years · All sexes

Timeline

2011 – 2015

Study locations (1)

• Groupe Hospitalier Pitié Salpêtrière, Paris, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Autosomal dominant cerebellar ataxia

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07099651
  Autosomal Dominant Spinocerebellar Ataxias and Social Cognition
  University Hospital, Angers

See all trials for Autosomal dominant cerebellar ataxia →